Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2018

01-09-2018 | Review

A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study

Authors: Elyse R. Thakur, Jordan Shapiro, Johanna Chan, Mark A. Lumley, Jeffrey A. Cully, Andrea Bradford, Hashem B. El-Serag

Published in: Digestive Diseases and Sciences | Issue 9/2018

Login to get access

Abstract

Background

Psychological treatments are efficacious for irritable bowel syndrome (IBS) in clinical trials; however, their effectiveness when conducted in gastroenterology practice settings is unclear.

Aim

To perform a systematic review of the types and effects of psychological treatments for IBS conducted in gastroenterology clinics.

Methods

We searched PubMed, EMBASE, and Cochrane central register. Studies conducted in gastroenterology clinic settings with IBS patients who were clinically referred from gastroenterology were included.

Results

We identified 3078 citations, of which only eight studies were eligible. Seven studies compared psychological treatments (average n = 25.7; range 12–43) to controls (average n = 25.4 patients; range 12–47), whereas one study compared two active “bonafide” interventions. Psychological treatments varied (cognitive–behavioral therapy, guided affective imagery, mindfulness, hypnosis, biofeedback, emotional awareness training). However, across approaches, short-term benefits were seen. IBS symptoms improved significantly among patients in cognitive and behavioral therapies, mindfulness-based stress reduction, guided affective imagery, and emotional awareness training compared with controls; there was a similar trend for gut-directed hypnotherapy. Similarly, IBS symptoms improved in a study of two active biofeedback and hypnosis treatments.

Conclusions

Evidence for the effectiveness of psychological treatment in gastroenterology practice is promising but limited. Study designs that involve a blending of efficacy and effectiveness components are needed.
Literature
2.
go back to reference Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120–2137.PubMedCrossRef Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120–2137.PubMedCrossRef
3.
go back to reference Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.PubMedCrossRef Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.PubMedCrossRef
4.
go back to reference Inadomi JM, Fennerty MB, Bjorkman D. The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18:671–682.PubMedCrossRef Inadomi JM, Fennerty MB, Bjorkman D. The economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18:671–682.PubMedCrossRef
5.
go back to reference Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care. 2005;11:S17–S26.PubMed Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care. 2005;11:S17–S26.PubMed
6.
go back to reference Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675–689.PubMedCrossRef Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675–689.PubMedCrossRef
7.
go back to reference Brandt LJCW, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104:S1–S35.PubMedCrossRef Brandt LJCW, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104:S1–S35.PubMedCrossRef
8.
go back to reference Chang L. The role of stress on physiological responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011;140:761.PubMedCrossRef Chang L. The role of stress on physiological responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011;140:761.PubMedCrossRef
9.
go back to reference Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Phyol Gastrointest Liver Physiol. 2001;280:G519–G524.CrossRef Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Phyol Gastrointest Liver Physiol. 2001;280:G519–G524.CrossRef
10.
go back to reference Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72:1100.PubMedCrossRef Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72:1100.PubMedCrossRef
11.
go back to reference Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981–994.PubMedCrossRef Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981–994.PubMedCrossRef
12.
go back to reference Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis. J Psychosom Res. 2014;77:1–12.PubMedCrossRef Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis. J Psychosom Res. 2014;77:1–12.PubMedCrossRef
13.
go back to reference Ljótsson B, Andersson G, Andersson E, et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11:110.PubMedPubMedCentralCrossRef Ljótsson B, Andersson G, Andersson E, et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11:110.PubMedPubMedCentralCrossRef
14.
go back to reference Mahvi-Shirazi M, Fathi-Ashtiani A, Rasoolzade-Tabatabaei S, et al. Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment. Arch Med Sci: AMS. 2012;8:123–129.PubMedPubMedCentralCrossRef Mahvi-Shirazi M, Fathi-Ashtiani A, Rasoolzade-Tabatabaei S, et al. Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment. Arch Med Sci: AMS. 2012;8:123–129.PubMedPubMedCentralCrossRef
15.
go back to reference Haghayegh SA, Kalantari M, Molavi H, Talebi M. The efficacy of cognitive-behavior group therapy on health-related quality of life, health anxiety and depression in patients with diarrhea-predominant irritable bowel syndrome. Pak J Med Sci. 2011;27:749–753. Haghayegh SA, Kalantari M, Molavi H, Talebi M. The efficacy of cognitive-behavior group therapy on health-related quality of life, health anxiety and depression in patients with diarrhea-predominant irritable bowel syndrome. Pak J Med Sci. 2011;27:749–753.
16.
go back to reference Tkachuk GA, Graff LA, Martin GL, et al. Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol Med Settings. 2003;10:57–69.CrossRef Tkachuk GA, Graff LA, Martin GL, et al. Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol Med Settings. 2003;10:57–69.CrossRef
17.
go back to reference Park S-H, Han KS, Kang C-B. Relaxation therapy for irritable bowel syndrome: a systematic review. Asian Nurs Res. 2014;8:182–192.CrossRef Park S-H, Han KS, Kang C-B. Relaxation therapy for irritable bowel syndrome: a systematic review. Asian Nurs Res. 2014;8:182–192.CrossRef
18.
go back to reference Shinozaki M, Kanazawa M, Kano M, et al. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2010;35:189–198.PubMedCrossRef Shinozaki M, Kanazawa M, Kano M, et al. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial. Appl Psychophysiol Biofeedback. 2010;35:189–198.PubMedCrossRef
19.
go back to reference Taneja I, Deepak KK, Poojary G, et al. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback. 2004;29:19–33.PubMedCrossRef Taneja I, Deepak KK, Poojary G, et al. Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study. Appl Psychophysiol Biofeedback. 2004;29:19–33.PubMedCrossRef
20.
go back to reference Fernandez C, Perez M, Amigo I, et al. Stress and contingency management in the treatment of irritable bowel syndrome. Stress Med. 1998;14:31–42.CrossRef Fernandez C, Perez M, Amigo I, et al. Stress and contingency management in the treatment of irritable bowel syndrome. Stress Med. 1998;14:31–42.CrossRef
21.
go back to reference Shaw G, Srivastava ED, Sadlier M, et al. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:36–42.PubMedCrossRef Shaw G, Srivastava ED, Sadlier M, et al. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:36–42.PubMedCrossRef
22.
go back to reference Webb AN, Kukuruzovic R, Catto‐Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. The Cochrane Library 2007. Webb AN, Kukuruzovic R, Catto‐Smith AG, Sawyer SM. Hypnotherapy for treatment of irritable bowel syndrome. The Cochrane Library 2007.
23.
go back to reference Lee HH, Choi YY, Choi M-G. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2014;20:152.PubMedPubMedCentralCrossRef Lee HH, Choi YY, Choi M-G. The efficacy of hypnotherapy in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2014;20:152.PubMedPubMedCentralCrossRef
24.
go back to reference Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings—results from two randomized, controlled trials. Am J Gastroenterol. 2012;107:276–285.PubMedCrossRef Lindfors P, Unge P, Arvidsson P, et al. Effects of gut-directed hypnotherapy on IBS in different clinical settings—results from two randomized, controlled trials. Am J Gastroenterol. 2012;107:276–285.PubMedCrossRef
25.
go back to reference Ford AC, Farhang S, Quigley EM, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1350–1365.PubMedCrossRef Ford AC, Farhang S, Quigley EM, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1350–1365.PubMedCrossRef
26.
go back to reference Zijdenbos IL, de Wit NJ, van der Heijden GJ, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. The Cochrane Library 2009. Zijdenbos IL, de Wit NJ, van der Heijden GJ, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. The Cochrane Library 2009.
27.
go back to reference Creed F, Guthrie E, Ratcliff J, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003;124:303–317.PubMedCrossRef Creed F, Guthrie E, Ratcliff J, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003;124:303–317.PubMedCrossRef
28.
go back to reference Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology. 1991;100:450–457.PubMedCrossRef Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology. 1991;100:450–457.PubMedCrossRef
29.
go back to reference Svedlund J, Sjodin I, Ottoson JO, et al. Controlled study of psychotherapy in irritable bowel syndrome. Lancet. 1983;322:589–592.CrossRef Svedlund J, Sjodin I, Ottoson JO, et al. Controlled study of psychotherapy in irritable bowel syndrome. Lancet. 1983;322:589–592.CrossRef
30.
go back to reference Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217.PubMedPubMedCentralCrossRef Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217.PubMedPubMedCentralCrossRef
31.
go back to reference Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93:1261–1267.PubMedPubMedCentralCrossRef Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93:1261–1267.PubMedPubMedCentralCrossRef
32.
go back to reference Longstreth G, Hawkey C, Mayer E, et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther. 2001;15:959–964.PubMedCrossRef Longstreth G, Hawkey C, Mayer E, et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther. 2001;15:959–964.PubMedCrossRef
33.
go back to reference Singal AG, Higgins PD, Waljee AK. A primer on effectiveness and efficacy trials. Clin Transla Gastroenterol. 2014;5:e45.CrossRef Singal AG, Higgins PD, Waljee AK. A primer on effectiveness and efficacy trials. Clin Transla Gastroenterol. 2014;5:e45.CrossRef
34.
go back to reference Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009;58:367–378.PubMedCrossRef Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009;58:367–378.PubMedCrossRef
35.
go back to reference Zernicke KA, Campbell TS, Blustein PK, et al. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med. 2013;20:385–396.PubMedCrossRef Zernicke KA, Campbell TS, Blustein PK, et al. Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med. 2013;20:385–396.PubMedCrossRef
36.
go back to reference Boltin D, Sahar N, Gil E, et al. Gut-directed guided affective imagery as an adjunct to dietary modification in irritable bowel syndrome. J Health Psychol. 2015;20:712–720.PubMedCrossRef Boltin D, Sahar N, Gil E, et al. Gut-directed guided affective imagery as an adjunct to dietary modification in irritable bowel syndrome. J Health Psychol. 2015;20:712–720.PubMedCrossRef
37.
go back to reference Farnam A, Somi MH, Farhang S, Mahdavi N, Besharat MA. The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial. J Psychiatr Pract. 2014;20:3–11.PubMedCrossRef Farnam A, Somi MH, Farhang S, Mahdavi N, Besharat MA. The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial. J Psychiatr Pract. 2014;20:3–11.PubMedCrossRef
38.
go back to reference Dobbin A, Dobbin J, Ross SC, et al. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome. J R Coll Physicians Edinb. 2013;43:15–23.PubMedCrossRef Dobbin A, Dobbin J, Ross SC, et al. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome. J R Coll Physicians Edinb. 2013;43:15–23.PubMedCrossRef
39.
go back to reference Wiklund I, Fullerton S, Hawkey C, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2009;38:947–954. Wiklund I, Fullerton S, Hawkey C, et al. An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol. 2009;38:947–954.
40.
go back to reference Francis C, Morris J, Whorwell P. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef Francis C, Morris J, Whorwell P. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef
41.
go back to reference Beck AT, Steer R, Brown G. Beck Depression Inventory Manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace Jovanovich; 1996. Beck AT, Steer R, Brown G. Beck Depression Inventory Manual. San Antonio, TX: The Psychological Corporation, Harcourt Brace Jovanovich; 1996.
42.
go back to reference Vassend O, Skrondal A. The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behav Res Ther. 1999;37:685–701.PubMedCrossRef Vassend O, Skrondal A. The problem of structural indeterminacy in multidimensional symptom report instruments. The case of SCL-90-R. Behav Res Ther. 1999;37:685–701.PubMedCrossRef
43.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.PubMedCrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.PubMedCrossRef
44.
go back to reference Spielberger CDGR, Lushene RE. STAI Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970. Spielberger CDGR, Lushene RE. STAI Manual for the State Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
45.
go back to reference Patrick DL, Drossman DA, Frederick IO, Dicesare J, Puder KL. Quality of life in persons with irritable bowel syndrome (development and validation of a new measure). Dig Dis Sci. 1998;43:400–411.PubMedCrossRef Patrick DL, Drossman DA, Frederick IO, Dicesare J, Puder KL. Quality of life in persons with irritable bowel syndrome (development and validation of a new measure). Dig Dis Sci. 1998;43:400–411.PubMedCrossRef
46.
go back to reference Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.PubMedCrossRef Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.PubMedCrossRef
47.
go back to reference Eypasch E, Wood-Dauphinee S, Williams J, Ure B, Neugeauer E, Troidl HP. The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg. 1993;64:264–274.PubMed Eypasch E, Wood-Dauphinee S, Williams J, Ure B, Neugeauer E, Troidl HP. The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg. 1993;64:264–274.PubMed
48.
go back to reference Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–1156.PubMedCrossRef Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–1156.PubMedCrossRef
49.
go back to reference Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27:94–102.PubMedCrossRef Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27:94–102.PubMedCrossRef
50.
go back to reference Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465.PubMedCrossRef Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465.PubMedCrossRef
51.
go back to reference Mikocka-Walus A, Turnbull D, Andrews JM, Moulding N, Wilson I, Holtmann G. Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Intern Med J. 2009;39:127–130.PubMedCrossRef Mikocka-Walus A, Turnbull D, Andrews JM, Moulding N, Wilson I, Holtmann G. Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Intern Med J. 2009;39:127–130.PubMedCrossRef
Metadata
Title
A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study
Authors
Elyse R. Thakur
Jordan Shapiro
Johanna Chan
Mark A. Lumley
Jeffrey A. Cully
Andrea Bradford
Hashem B. El-Serag
Publication date
01-09-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5095-3

Other articles of this Issue 9/2018

Digestive Diseases and Sciences 9/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.